RT @icthicmagazine: ➡Very informative report about #COVID19 and thrombotic or thromboembolic disease, with the contribution of several expe…
RT @MacDeptMed: Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, managem…
RT @MacDeptMed: Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, managem…
RT @MacDeptMed: Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, managem…
RT @CIMSFHUVH: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up https:…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up https://t.co/94bKFpEYQe
@SenSchumer COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | JACC: Journal of the American College of Cardiology https://t.co/Yhv90linQ7 What's the connection between Coronavirus and AR
@MStranslate COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | JACC: Journal of the American College of Cardiology https://t.co/Yhv90linQ7 What's the connection between Coronavirus and A
Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, management, and outcomes of patients with #COVIDー19 who develop venous or arterial #thrombosis. Read the full paper📜⬇️ https://t.co/5VTj7124
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @JACCJournals: Today in #JACC: An international collaborative of clinicians summarize outcomes in #COVID19 patients with thrombotic dise…
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @hfuentesbayne: Organized directives for prevention & mng of thrombotic disease in #COVID19. Thanks @bbikdeli @AlexSpyropoul @Angiologis…
RT @hfuentesbayne: Organized directives for prevention & mng of thrombotic disease in #COVID19. Thanks @bbikdeli @AlexSpyropoul @Angiologis…
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…
RT @NATFthrombosis: Important, timely work by @bbikdeli and colleagues on #COVID19 and #thrombosis https://t.co/AWJcAkHqOR
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @hfuentesbayne: Organized directives for prevention & mng of thrombotic disease in #COVID19. Thanks @bbikdeli @AlexSpyropoul @Angiologis…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @JACCJournals: Today in #JACC: An international collaborative of clinicians summarize outcomes in #COVID19 patients with thrombotic dise…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…
Organized directives for prevention & mng of thrombotic disease in #COVID19. Thanks @bbikdeli @AlexSpyropoul @Angiologist @MaryCushmanMD @AJTafur @mmonrealriete @DJC6998 @bhwords @GBarnesMD @MarcCarrier1 and others. @JACCJournals @HTRSFellows @isth ht
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @isth: Don’t miss this paper just published in @JACCJournals titled: #COVID19 and #Thrombotic or Thromboembolic Disease: Implications fo…
RT @JerroldLevy: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Pr... https://t.co/xe0iVm9hla
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. - PubMed - NCBI https://t.co/bqppSZmEAh
RT @JACCJournals: Today in #JACC: An international collaborative of clinicians summarize outcomes in #COVID19 patients with thrombotic dise…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @LiverpoolCCS: Must read! COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Fo…
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…
RT @JACCJournals: Today in #JACC: An international collaborative of clinicians summarize outcomes in #COVID19 patients with thrombotic dise…
@neurognanapavan COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | JACC: Journal of the American College of Cardiology https://t.co/Yhv90linQ7 https://t.co/qrUPSmZluX
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @JACCJournals: Today in #JACC: An international collaborative of clinicians summarize outcomes in #COVID19 patients with thrombotic dise…
@Brandon_Beaber COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | JACC: Journal of the American College of Cardiology https://t.co/Yhv90linQ7
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @Office_j: 【備忘】JACC誌に、COVID-19例の血栓症、血栓塞栓症予防に関するレビュー。 https://t.co/PCtOesMwXY [Free] https://t.co/ttRZePu9FG
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @icthicmagazine: ➡Very informative report about #COVID19 and thrombotic or thromboembolic disease, with the contribution of several expe…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @JACCJournals: Today in #JACC: An international collaborative of clinicians summarize outcomes in #COVID19 patients with thrombotic dise…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PharmacyToDose: "COVID-19 and Thrombotic Disease" Published in JACC and endorsed by ISTH. Major shout-out to 2 Pharmacists on the aut…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @Office_j: 【備忘】JACC誌に、COVID-19例の血栓症、血栓塞栓症予防に関するレビュー。 https://t.co/PCtOesMwXY [Free] https://t.co/ttRZePu9FG
RT @PulmCrit: JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guid…
JACC guideline on PE/DVT in COVID: - nothing fundamentally new here - no consensus about empiric anticoagulation (1/2) (guideline: https://t.co/EpXfvjnFRh) (IBCC section: https://t.co/IIR8JOzQ4W) https://t.co/882tbhYWyG
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
【備忘】JACC誌に、COVID-19例の血栓症、血栓塞栓症予防に関するレビュー。 https://t.co/PCtOesMwXY [Free] https://t.co/ttRZePu9FG
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
RT @paomorejon: No hay que ovidarse de los efectos tromboticos en el ❤️ El daño miocárdico está presente 👥30% desarrolla miocardiopatía en…
RT @Angiologist: Thrombosis and #COVID19? There's a @JACCJournals review on what we know this far (more to come!). Thank you to @bbikdeli f…
RT @gonzaeperez: COVID-19 Y EVENTOS TROMBÓTICOS O EMBÓLICOS Implicancias para la prevención, tratamiento antitrombótico y seguimiento Revi…
RT @isth: The ISTH has endorsed the latest guidance published in the @JACCJournals: #COVID19 and Thrombotic or Thromboembolic Disease: Impl…
RT @ProfMakris: This is probably the best, and certainly most comprehensive review on COVID-19 and thrombosis. https://t.co/Tz0XNTmKhL http…